Dr. Jasmin Honkamäki
Dr. Jasmin Honkam\u00e4ki

Dr. Jasmin Honkamäki

MD, PhD — Physician & Researcher

Dr. Jasmin Honkamäki is a Finnish physician and medical researcher with special interest and expertise in respiratory health, preventive medicine, and evidence-based health optimization and longevity. She holds a medical degree and completed her doctoral thesis at Tampere University on epidemiology of asthma.

Currently, Dr. Honkamäki is employed as a chief physician at Terveystalo, largest Finnish private healthcare company, where she is responsible of medical quality of general and specialized medicine in a middle-sized private healthcare unit with appointment and hospital services. She has completed a qualification of occupational medicine, and is specializing to healthcare through her administrative work, including supervising and guiding other physicians.

Her research has focused on adult asthma diagnosis age and how it affects asthma prognosis, symptom burden, and multimorbidity. She is currently studying risk factors of chronic cough, and asthma associations with cardiovascular, mental, and metabolic diseases.

Dr. Honkamäki lives in Finland practicing the health optimization protocols that serve as the foundation of her method. Healthspan-optimizing exercise in all seasons, rich gut microbiome favouring diet and exposure to microbes in the environment with minimal processed foods, sobriety since 2024 and never smoker status, health monitoring through wearables and regular clinical testing, attention to indoor air quality, supplements and medications optimized with status quo, frequent sauna use, and circadian rhythm alignment as well as controlled caffeine intake are not just theoretical recommendations, but based on daily implementation.

Jasmin playing tennis

Education

MD — Tampere University, Finland

PhD — Tampere University — Doctoral thesis: Epidemiology of Asthma by Age at Diagnosis

Current Position

Chief Physician, Terveystalo

Previous

Regional Chief Physician, Mehiläinen

Corresponding Physician at the Emergency Department, Hospital of Southern Ostrobothnia

Team Physician of Men Under 20 Ice Hockey League, Finnish Student Health Service, Acute Psychiatric and Prison Hospital physician

Languages

Finnish (native)

English (fluent)

Swedish (proficient)

In academia

8+ peer-reviewed original publications

360+ citations

Research focus: asthma, multimorbidity, occupational exposures, respiratory symptoms

Dr. Jasmin Honkamäki in clinical setting

Original Publications

Honkamäki J. Asthma epidemiology by age at diagnosis. Doctoral thesis, Tampere University, April 2024.

Doctoral thesis synthesizing how age at asthma diagnosis shapes long-term prognosis, symptom patterns, comorbidity burden, and remission likelihood across the lifespan.

Honkamäki J. et al. Nonrespiratory diseases in adults without and with asthma by age at asthma diagnosis. J Allergy Clin Immunol Pract. 2023;11(2):555-563.e4.

Examined how nonrespiratory comorbidities — including cardiovascular, metabolic, and psychiatric conditions — differ between adults with and without asthma, stratified by the age at which asthma was first diagnosed.

Hisinger-Mölkänen H. et al. Age at asthma diagnosis is related to prevalence and characteristics of asthma symptoms. World Allergy Organ J. 2022;15(9):100675.

Showed that symptom prevalence and characteristics vary significantly depending on the age at asthma diagnosis, with adult-diagnosed patients reporting different symptom profiles than those diagnosed in childhood.

Andersen H. et al. NSAID-exacerbated respiratory disease: a population study. ERJ Open Res 2022;24;8(1):00462-2021.

Population-level study estimating the prevalence and clinical characteristics of NSAID-exacerbated respiratory disease, highlighting its underdiagnosis and association with more severe asthma.

Andersen H. et al. Influence of childhood exposure to a farming environment on age at asthma diagnosis in a population-based study. J Asthma Allergy 2021;7;14:1081-1091.

Investigated whether growing up on a farm delays or prevents asthma being diagnosed, finding that childhood farming exposure influences the age at which asthma is first diagnosed in adulthood.

Andersen H. et al. Dyspnea has an association with lifestyle: differences between Swedish and Finnish speaking persons in Western Finland. Eur Clin Resp J 2020;10;8(1):1855702.

Explored how lifestyle factors such as physical activity, smoking, and BMI associate with breathlessness, revealing differences between language groups in a bilingual Finnish population.

Honkamäki J. et al. Asthma remission by age at diagnosis and gender in a population-based study. J Allergy Clin Immunol Pract 2020;S2213-2198(20)31347-7.

Demonstrated that asthma remission rates differ substantially by age at diagnosis and gender, with adult-diagnosed asthma showing lower remission probability than childhood-diagnosed disease.

Pakkasela J. et al. Age-specific incidence of allergic and non-allergic asthma. BMC Pulm Med 2020;20(1):9.

Quantified incidence rates of allergic versus non-allergic asthma across age groups, showing that non-allergic asthma dominates in older adults while allergic asthma peaks in younger populations.

Honkamäki J. et al. Age- and gender-specific incidence of new asthma diagnosis from childhood to late adulthood. Respir Med 2019;154:56-62.

Mapped new asthma diagnosis incidence across the full lifespan, revealing that adult-diagnosed asthma is more common than previously recognized, especially among women in middle age.